Cargando…
Overcoming Resistance to Selective Serotonin Reuptake Inhibitors: Targeting Serotonin, Serotonin-1A Receptors and Adult Neuroplasticity
Major depressive disorder (MDD) is the most prevalent mental illness contributing to global disease burden. Selective serotonin (5-HT) reuptake inhibitors (SSRIs) are the first-line treatment for MDD, but are only fully effective in 30% of patients and require weeks before improvement may be seen. A...
Autores principales: | Vahid-Ansari, Faranak, Zhang, Min, Zahrai, Amin, Albert, Paul R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6502905/ https://www.ncbi.nlm.nih.gov/pubmed/31114473 http://dx.doi.org/10.3389/fnins.2019.00404 |
Ejemplares similares
-
Neuroplastic effects of a selective serotonin reuptake inhibitor in relearning and retrieval
por: Reed, M.B., et al.
Publicado: (2021) -
Effects of Selective Serotonin Reuptake Inhibitors on Interregional Relation of Serotonin Transporter Availability in Major Depression
por: James, Gregory M., et al.
Publicado: (2017) -
Sentiment Analysis of Online Reviews for Selective Serotonin Reuptake Inhibitors and Serotonin–Norepinephrine Reuptake Inhibitors
por: Compagner, Chad, et al.
Publicado: (2021) -
Fluoxetine-induced recovery of serotonin and norepinephrine projections in a mouse model of post-stroke depression
por: Zahrai, Amin, et al.
Publicado: (2020) -
Clinical pharmacology of serotonin selective reuptake inhibitors /
por: Preskorn, Sheldon
Publicado: (1996)